Literature DB >> 7538103

Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis.

K Takeuchi1, A Yamaguchi, T Urano, T Goi, G Nakagawara, H Shiku.   

Abstract

Splice variants of CD44 are overexpressed in human lung, breast, and colon carcinoma cell lines. This study was conducted to clarify the association between the expression of CD44 variant exons 8-10 and metastatic potential in human colorectal cancer. We found that the expression of a CD44 splice variant containing exons v8-10 was increased in all of 60 colorectal cancer specimens examined compared with matched normal colerectal mucosa, as determined by Northern blotting. Expression of CD44 variant exons 8-10 did not significantly correlate with histological type, depth of tumor invasion, lymphatic invasion, venous invasion, or lymph node metastasis. However, the level of CD44 variant exon 8-10 expression was significantly higher in carcinomas associated with liver metastasis than in those without liver metastasis. In addition, expression of CD44 variant exons 8-10 in the liver metastases was more intense than that in the primary colorectal cancers. These findings indicated that this domain of the CD44 glycoprotein encoded by exons v8-10 may play an important role in tumor hematogenous metastasis of human colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538103      PMCID: PMC5920816          DOI: 10.1111/j.1349-7006.1995.tb03053.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  26 in total

1.  The cell surface hyaluronate binding sites of invasive human bladder carcinoma cells.

Authors:  R E Nemec; B P Toole; W Knudson
Journal:  Biochem Biophys Res Commun       Date:  1987-11-30       Impact factor: 3.575

2.  A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man.

Authors:  S T Jalkanen; R F Bargatze; L R Herron; E C Butcher
Journal:  Eur J Immunol       Date:  1986-10       Impact factor: 5.532

3.  Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium.

Authors:  R L Idzerda; W G Carter; C Nottenburg; E A Wayner; W M Gallatin; T St John
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

4.  The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior.

Authors:  W Rudy; M Hofmann; R Schwartz-Albiez; M Zöller; K H Heider; H Ponta; P Herrlich
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

5.  Significance of CD44 gene products for cancer diagnosis and disease evaluation.

Authors:  Y Matsumura; D Tarin
Journal:  Lancet       Date:  1992-10-31       Impact factor: 79.321

6.  Expression of CD44R1 adhesion molecule in colon carcinomas and metastases.

Authors:  K K Tanabe; L M Ellis; H Saya
Journal:  Lancet       Date:  1993-03-20       Impact factor: 79.321

7.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

Authors:  G R Screaton; M V Bell; D G Jackson; F B Cornelis; U Gerth; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Participation in normal immune responses of a metastasis-inducing splice variant of CD44.

Authors:  R Arch; K Wirth; M Hofmann; H Ponta; S Matzku; P Herrlich; M Zöller
Journal:  Science       Date:  1992-07-31       Impact factor: 47.728

9.  Prevention of tumor metastasis formation by anti-variant CD44.

Authors:  S Seiter; R Arch; S Reber; D Komitowski; M Hofmann; H Ponta; P Herrlich; S Matzku; M Zöller
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

10.  A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.

Authors:  K H Heider; M Hofmann; E Hors; F van den Berg; H Ponta; P Herrlich; S T Pals
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

View more
  13 in total

1.  The beta-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression.

Authors:  Vânia Gonçalves; Paulo Matos; Peter Jordan
Journal:  RNA       Date:  2008-10-24       Impact factor: 4.942

Review 2.  Forms and functions of CD44.

Authors:  G Borland; J A Ross; K Guy
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

Review 3.  CD44 and the adhesion of neoplastic cells.

Authors:  Z Rudzki; S Jothy
Journal:  Mol Pathol       Date:  1997-04

4.  Alterative expression of the collagenase and adhesion molecules in the highly metastatic clones of human colonic cancer cell lines.

Authors:  Y Nakayama; K Okazaki; K Shibao; T Sako; K Hirata; N Nagata; M Kuwano; H Itoh
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

5.  Establishment and characterization of human pancreatic carcinoma lines with a high metastatic potential in the liver of nude mice.

Authors:  T Shishido; T Yasoshima; K Hirata; R Denno; M Mukaiya; H Ura; K Yamaguchi; S Kawaguchi; N Sato
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

6.  Rapid and reliable detection of CD44 variants in gastric carcinoma using a nested reverse transcription-polymerase chain reaction.

Authors:  Yan Wang; Yuhong Liu; Bai Xiao
Journal:  Oncol Lett       Date:  2015-09-02       Impact factor: 2.967

Review 7.  Colorectal cancer: genetics of development and metastasis.

Authors:  Tetsuji Takayama; Koji Miyanishi; Tsuyoshi Hayashi; Yasushi Sato; Yoshiro Niitsu
Journal:  J Gastroenterol       Date:  2006-03       Impact factor: 7.527

Review 8.  Colon cancer stem cells: implications in carcinogenesis.

Authors:  Matthew A Sanders; Adhip P N Majumdar
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

9.  Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis.

Authors:  S Zhu; Z Chen; A Katsha; J Hong; A Belkhiri; W El-Rifai
Journal:  Oncogene       Date:  2015-06-29       Impact factor: 9.867

10.  Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.

Authors:  Kohei Otsubo; Kaname Nosaki; Chiyo K Imamura; Hiroaki Ogata; Akitaka Fujita; Shinya Sakata; Fumihiko Hirai; Gouji Toyokawa; Eiji Iwama; Taishi Harada; Takashi Seto; Mitsuhiro Takenoyama; Takeshi Ozeki; Taisei Mushiroda; Mieko Inada; Junji Kishimoto; Kenji Tsuchihashi; Kentaro Suina; Osamu Nagano; Hideyuki Saya; Yoichi Nakanishi; Isamu Okamoto
Journal:  Cancer Sci       Date:  2017-07-26       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.